What's new
Fantasy Football - Footballguys Forums

This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

***OFFICIAL CYDY/Leronlimab Thread*** (3 Viewers)

It’s shtick, if you can understand the shtick then it’s bad shtick. If you still don’t get it then pm shuke
It’s schtick that I’ve only seen in the streaming threads but it’s pretty bad there. Last thing we need is stupid stuff cluttering things up. We already have a lot of bad jokes in here.

 
This is as good or better than Remdesivir.  But Rem had someone change the Primary endpoint for them before the trial ended.  

This whole approval thing, atleast how it worked out for Remdesivir, seems very sketchy.
Lol. You think it’s sketchy now? It was always sketchy and had way more to do with $$$s than saving lives. No offense to Trump and his alien DNA doctor, but if Remdesivir and hydroxychloroquine and the steroids were great we wouldn’t be losing 1k lives a day.

Our buddy Whyatt was really touting this one above and it failed. If I am reading it right there were actually more deaths with the drug than the placebo. Stock wise (I’d be fine breaking even if a different drug made CV go away) this is good for us.

 
stbugs said:
Lol. You think it’s sketchy now? It was always sketchy and had way more to do with $$$s than saving lives. No offense to Trump and his alien DNA doctor, but if Remdesivir and hydroxychloroquine and the steroids were great we wouldn’t be losing 1k lives a day.

Our buddy Whyatt was really touting this one above and it failed. If I am reading it right there were actually more deaths with the drug than the placebo. Stock wise (I’d be fine breaking even if a different drug made CV go away) this is good for us.
Adam Feuerstein for months- CYDY is trash, untrustworthy, BLA, BLA BLA 

  • fbg CYDYS  - Adam Feuerstein POS short, CYDY anecdotal evidence great, not selling 
Me for months - many red flags, have fbgs considered competition like Tocilizumab - anecdotal evidence looks good 

  • fbg CYDYs - Whyatt POS short, CYDY anecdotal evidence great, not selling
me few weeks ago - outsiders see CYDY as pump and dump

  • fbg CYDYs - Whyatt POS short, CYDY anecdotal evidence great, not selling
  • Days later - several fbg get concerned, sell all or part
WSJ today - many red flag, looks like gambling, what’s going on here, pump and dump?

  • fbg CYDYs - CYDY anecdotal evidence great, not selling??
  • by the way, whyatt made bad call on based on Tocilizumab anecdotal evidence 
lmao 

 
Adam Feuerstein for months- CYDY is trash, untrustworthy, BLA, BLA BLA 

  • fbg CYDYS  - Adam Feuerstein POS short, CYDY anecdotal evidence great, not selling 
Me for months - many red flags, have fbgs considered competition like Tocilizumab - anecdotal evidence looks good 

  • fbg CYDYs - Whyatt POS short, CYDY anecdotal evidence great, not selling
me few weeks ago - outsiders see CYDY as pump and dump

  • fbg CYDYs - Whyatt POS short, CYDY anecdotal evidence great, not selling
  • Days later - several fbg get concerned, sell all or part
WSJ today - many red flag, looks like gambling, what’s going on here, pump and dump?

  • fbg CYDYs - CYDY anecdotal evidence great, not selling??
  • by the way, whyatt made bad call on based on Tocilizumab anecdotal evidence 
lmao 
You are the Night King aren't you?  

 
Adam Feuerstein for months- CYDY is trash, untrustworthy, BLA, BLA BLA 

  • fbg CYDYS  - Adam Feuerstein POS short, CYDY anecdotal evidence great, not selling 
Me for months - many red flags, have fbgs considered competition like Tocilizumab - anecdotal evidence looks good 

  • fbg CYDYs - Whyatt POS short, CYDY anecdotal evidence great, not selling
me few weeks ago - outsiders see CYDY as pump and dump

  • fbg CYDYs - Whyatt POS short, CYDY anecdotal evidence great, not selling
  • Days later - several fbg get concerned, sell all or part
Actually, the POS moniker is completely wrong.  The treatment here has been quite the opposite toward you.

AF, on the other hand, is a POS.  .500 ain't bad.

 
Last edited by a moderator:
You have to admit that if this does overcome the odds, its one of the most improbable stories of all time. 

No one in the industry takes them seriously.  Mainstream media won't get very close.  The government is not helping at all.  The drug itself is not new, they have been trying a while now, no approvals yet.  When it does get media coverage, there is at least a 50% chance someone is taking a shot at them.

We know the CEO gets no respect.  Doesn't seem like the drug gets any respect either.

This is a constant test of faith and I have little generally.

 

 
You have to admit that if this does overcome the odds, its one of the most improbable stories of all time. 

No one in the industry takes them seriously.  Mainstream media won't get very close.  The government is not helping at all.  The drug itself is not new, they have been trying a while now, no approvals yet.  When it does get media coverage, there is at least a 50% chance someone is taking a shot at them.

We know the CEO gets no respect.  Doesn't seem like the drug gets any respect either.

This is a constant test of faith and I have little generally.

 
Aka the definition of homerun or bust.  So really no different from when most of us bought in sub $1

 
Nader said in that video yesterday the m/m data will be next week so it certainly won’t be before then (or even then most likely) 

 
Just for AF related news.  Our favorite website STAT News a couple of days ago erroneously reported that the NVAX vaccine trials had hospitalized 8 patients.  Share price dropped from $180 to $105 on the news.  Turns out that news was completely false and they rescinded the article and share price bounced right back to $180.

 
:Kramerslappingmoneyontable:

I'm Out!!

Good luck to everyone else with this stock. Hope it works out. Had a small gain the first portion I sold and now a small loss. 

 
Just for AF related news.  Our favorite website STAT News a couple of days ago erroneously reported that the NVAX vaccine trials had hospitalized 8 patients.  Share price dropped from $180 to $105 on the news.  Turns out that news was completely false and they rescinded the article and share price bounced right back to $180.
You got to wonder if anyone is investigating them. They did the same thing with Gilead driving the stock up and down.

 
:Kramerslappingmoneyontable:

I'm Out!!

Good luck to everyone else with this stock. Hope it works out. Had a small gain the first portion I sold and now a small loss. 
Same here.  Thanks so much, Chet.  Good luck to all.  Might be back in if it keeps falling over the next few weeks.

 
Another hit tweet by AF on NP  Man we are getting the stuffing beat out of us.

Here's part of it.

I have reported on many promotional, misleading statements made by $CYDY CEO Nader Pourhassan about its drug leronlimab. Here he is again, last night, trying to spin a study in Covid-19 patients without disclosing real data. Word-for-word transcription:

 
I'm pot committed and all in. No more to invest. Hope SP holds in the green as I was later getting in then some others.

 
Last edited by a moderator:
Took this from another board. 

It is impossible for the DSMC (Data Safety Monitoring Committee) to recommend stopping CYDY's Serious/Critical COVID19 trial early for efficacy because the minimum patient count agreed to by the FDA to reach statistically relevant data is 195 patients and less than that were enrolled when the DSMC met last week. Anyone making an issue of this is lying or ignorant. The finding by the DSMC that Leronlimab has no safety concerns is huge. The fact that the DSMC did NOT REDUCE the threshold for efficacy in this instance, during this COVID19 Pandemic, is huge, because FDA is on orders from the Administration to get as many useful options approved and out there as possible and for lesser efficacious treatments the DSMCs are reducing the primary endpoints because the treatments are failing to meet them and are instead saying, to paraphrase, try to find something else that this drug is showing useful so we can approve it. Case in point in Humanagen's drug and Relief Therapeutics. Besides those, nearly all other treatments for COVID19 are failing their trials and being stopped for INEFFICACY, including two last week or so from Big Pharmas. CYDY is the only company in the lead on this. It's so obvious.

 
Emailed the guys that wrote the WSJ article yesterday and asked them why they didn't quote any doctors about the drug and just focused on Nader.

They responded.

Basically they think Patterson has too many conflicts to take his word at face value.  They also reached out to the Doctor at Montefiore for a comment but since that Dr wouldn't state anything about the drug's efficacy (not surprising), they didn't see any reason to include.

 

Users who are viewing this thread

Back
Top